You have 9 free searches left this month | for more free features.

Drug-drug interaction

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Drug-drug Interaction Study Trial in Hyderabad (SPRYCEL® (dasatinib) 100 mg Film-Coated Tablets in combination with Omeprazole

Completed
  • Drug-drug Interaction Study
  • SPRYCEL® (dasatinib) 100 mg Film-Coated Tablets in combination with Omeprazole Delayed-Release Capsules USP, 40 mg
  • Hyderabad, India
    QPS Bioserve India Pvt Limited
Nov 20, 2023

Drug Drug Interaction Trial (Midazolam, Omeprazole, Rosuvastatin)

Not yet recruiting
  • Drug Drug Interaction
  • (no location specified)
Sep 4, 2023

Diabetes in Adults Trial in Shanghai (Hydrochlorothiazide?Henagliflozin Proline)

Completed
  • Diabetes in Adults
  • Hydrochlorothiazide、Henagliflozin Proline
  • Shanghai, Shanghai, China
    Shanghai Xuhui Central Hospital
Oct 12, 2023

Healthy, Drug-Drug Interaction Trial in Shanghai (JMKX000623, Metformin)

Active, not recruiting
  • Healthy
  • Drug-Drug Interaction
  • Shanghai, Shanghai, China
    Huashan Hospital Fudan University
Sep 30, 2023

Myelofibrosis Trial in Jinan (TQ05105 tablets, Itraconazole capsule, Rifampicin Capsule)

Not yet recruiting
  • Myelofibrosis
  • TQ05105 tablets
  • +2 more
  • Jinan, Shandong, China
    Shandong Provincial Hospital
Aug 30, 2023

Drug Drug Interaction Trial in Guangzhou (Digoxin, Rosuvastatin, ZSP1273)

Recruiting
  • Drug Drug Interaction
  • Guangzhou, China
    The First Affiliated Hospital of Guangzhou University of Chinese
Jul 13, 2023

Healthy Volunteer Trial in Grayslake (ABBV-903, Midazolam)

Not yet recruiting
  • Healthy Volunteer
  • Grayslake, Illinois
    Acpru /Id# 254970
May 31, 2023

Drug Interactions Trial in Gyeonggi-do (Methotrexate Sodium, Rifampicin)

Enrolling by invitation
  • Drug Interactions
  • Gyeonggi-do, Korea, Republic of
    Seoul National University Bundang Hospital
Oct 25, 2023

Healthy Participant Trial in Changchun (GST-HG171/Ritonavir, Itraconazole)

Completed
  • Healthy Participant
  • Changchun, Jilin, China
    The first hospital of Jilin University
Oct 11, 2023

NSCLC Trial (HLX208, Itraconazole 200 mg, Rifampicin)

Not yet recruiting
  • NSCLC
  • (no location specified)
Jun 5, 2023

Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Tempe (CCX168, Midazolam, Celecoxib)

Completed
  • Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
  • Tempe, Arizona
    Celerion
Aug 15, 2023

Healthy Volunteer Study Trial in Québec (Cohort 1 BEM + Ruzasvir, Cohort 2 Ruzasvir + BEM)

Recruiting
  • Healthy Volunteer Study
  • Cohort 1 BEM + Ruzasvir
  • Cohort 2 Ruzasvir + BEM
  • Québec, Montreal, Quebec, Canada
    Atea Study Site
Feb 9, 2023

Healthy Volunteers Trial in Edegem (AGMB-129, MDZ)

Recruiting
  • Healthy Volunteers
  • Edegem, Belgium
    SGS Belgium
Jun 30, 2023

Drug Interaction Trial in Beijing (ZX-7101A, Oseltamivir, ZX-7101A and Oseltamivir)

Recruiting
  • Drug Interaction
  • Beijing, Beijing, China
    Peking University Third Hospital
Sep 21, 2023

Healthy Volunteers Trial (BMS-986196, Caffeine, Montelukast)

Not yet recruiting
  • Healthy Volunteers
  • (no location specified)
May 1, 2023

Healthy Volunteers Trial in Jeonju (RLD2301, RLD2007)

Recruiting
  • Healthy Volunteers
  • Jeonju, Jeollabuk-do, Korea, Republic of
    Jeonbuk University Hospital
May 8, 2023

Multiple Sclerosis Trial in Saint Paul (Tolebrutinib, gemfibrozil, rifampicin)

Completed
  • Multiple Sclerosis
  • Saint Paul, Minnesota
    Prism Research-Site Number:8400001
Sep 26, 2023

T2DM Trial (Chiglitazar, Empagliflozin, Atorvastatin)

Not yet recruiting
  • T2DM
  • (no location specified)
Dec 27, 2022

Healthy Female Volunteers Trial (BMS-986196, Loestrin)

Not yet recruiting
  • Healthy Female Volunteers
  • (no location specified)
May 26, 2023

Addiction, Opioid Use, Substance Use Disorders Trial (Placebo, Auvelity)

Not yet recruiting
  • Addiction
  • +3 more
  • (no location specified)
Aug 3, 2023

Drug Drug Interaction Trial in Seoul (DWC202313, DWC202314)

Recruiting
  • Drug Drug Interaction
  • Seoul, Korea, Republic of
    H Plus YANGJI Hospital
Nov 5, 2023

Idiopathic Pulmonary Fibrosis Trial in Adelaide (taladegib, nintedanib)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Adelaide, South Australia, Australia
    Research Site
Apr 5, 2023

PHN - Post-Herpetic Neuritis Trial in Beijing (HSK16149,probenecid, cimetidine)

Recruiting
  • PHN - Post-Herpetic Neuritis
  • HSK16149,probenecid, cimetidine
  • Beijing, China
    Beijing Jishuitan Hoispital
May 21, 2023

COVID-19 Trial in London (ALG-097558, Placebo, Midazolam)

Not yet recruiting
  • COVID-19
  • London, United Kingdom
    Hammersmith Medicines Research
Apr 21, 2023

Healthy Volunteers Trial in Jinan (Cohort 1: SIM0417/ritonavir and itraconazole, Cohort 2: SIM0417/ritonavir and rifampicin,

Active, not recruiting
  • Healthy Volunteers
  • Cohort 1: SIM0417/ritonavir and itraconazole
  • +2 more
  • Jinan, Shandong, China
    Shandong First Medical University
Jan 13, 2023